BCX-3607

Overview

BCX-3607 is an orally active tissue factor/factor VIIa ( TF-FVIIa ) inhibitor ( IC 50 : 4 nM). BCX-3607 blocks the extrinsic coagulation pathway by inhibiting the TF-FVIIa complex and significantly prolongs the prothrombin time (PT). BCX-3607 has a higher selectivity for TF-FVIIa than other serine proteases (such as thrombin , FXa, etc.). BCX-3607 can reduce thrombus weight and inflammatory response, and has both anti-thrombotic and anti-inflammatory effects. BCX-3607 can be used in the study of thrombosis-related diseases.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Research Areas > Cardiovascular Disease

Product Information

• Catalog No.: HY-172905
• CAS No.: 885684-79-7
• Molecular Formula: C27H29N5O3
• Molecular Weight: 471.55
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source